Ke Xu

1.7k total citations
73 papers, 1.3k citations indexed

About

Ke Xu is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Ke Xu has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 19 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Ke Xu's work include Bladder and Urothelial Cancer Treatments (11 papers), Functional Brain Connectivity Studies (9 papers) and Advanced Neuroimaging Techniques and Applications (8 papers). Ke Xu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Functional Brain Connectivity Studies (9 papers) and Advanced Neuroimaging Techniques and Applications (8 papers). Ke Xu collaborates with scholars based in China, United States and Australia. Ke Xu's co-authors include Chuanyu Sun, Weihong Ding, Guowei Xia, Yuancheng Gou, Qiang Ding, Qingfeng Hu, Shijun Tong, Lingtao Kong, Yanqing Tang and Zhongqing Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and NeuroImage.

In The Last Decade

Ke Xu

67 papers receiving 1.3k citations

Peers

Ke Xu
Comparison fields: 5 of 112
  • Molecular Biology 318
  • Cognitive Neuroscience 310
  • Surgery 229
  • Oncology 210
  • Radiology, Nuclear Medicine and Imaging 195
Replace Jörg Marienhagen with:
Jörg Marienhagen Germany
Yunhua Wang China
Nanette Freedman Israel
R. A. Dierckx Belgium
Agostino Chiaravalloti Italy
Yu‐Chiau Shyu Taiwan
Yaming Li China
E. Klieser Austria
Christina Antke Germany
Liling Long China
Jörg Marienhagen Germany View profile →
Citations per field, relative to Ke Xu
Ke Xu · 1×
Citations per year, relative to Ke Xu
Ke Xu · 1×

Countries citing papers authored by Ke Xu

Since Specialization
Citations

This map shows the geographic impact of Ke Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Xu more than expected).

Fields of papers citing papers by Ke Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Xu. The network helps show where Ke Xu may publish in the future.

Co-authorship network of co-authors of Ke Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Xu. A scholar is included among the top collaborators of Ke Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Xu. Ke Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 5
2 0
3 1
4 6
5 0
6 0
7 11
8 4
9 47
10 37
11 5
12
Preparation of AS1411 Aptamer Modified Mn-MoS2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma
1
13 70
14 7
15 0
16 68
17 33
18 39
19 9
20 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026